{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:03:53Z","timestamp":1791104633045,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.pharma.2008.11.004","type":"journal-article","created":{"date-parts":[[2009,2,15]],"date-time":"2009-02-15T04:30:49Z","timestamp":1234672249000},"page":"116-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Actualit\u00e9s de la maladie d\u2019Alzheimer"],"prefix":"10.1016","volume":"67","author":[{"given":"B.","family":"Dubois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2008.11.004_bib1","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IV-TR). 4th - Text Revised ed. Washington, DC. 2000."},{"key":"10.1016\/j.pharma.2008.11.004_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease \u2013 Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.56.9.1143","article-title":"Practice parameter: diagnosis of dementia (an evidence-based review). Report of the quality standards subcommittee of the Amerian Academy of Neurology","volume":"56","author":"Knopman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1468-1331.2006.01605.x","article-title":"Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline","volume":"14","author":"Waldemar","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pharma.2008.11.004_bib6","first-page":"209","article-title":"Standardisation et \u00e9talonnage fran\u00e7ais du \u00ab\u00a0Mini Mental State\u00a0\u00bb version Greco","volume":"13","author":"Kalafat","year":"2003","journal-title":"Neuropsychol Rev"},{"key":"10.1016\/j.pharma.2008.11.004_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S1041610295001815","article-title":"Usefulness of the clinical dementia rating scale in screening for dementia","volume":"7","author":"Juva","year":"1995","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.pharma.2008.11.004_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archneur.55.3.349","article-title":"A 7-minute neurocognitive screening battery highly sensitive to Alzheimer's disease","volume":"55","author":"Solomon","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib9","series-title":"Geriatric psychiatry: a handbook for psychiatrist and primary care physicians","first-page":"77","article-title":"Mental status examination for organic mental syndrome in the elderly patient","author":"Mattis","year":"1976"},{"key":"10.1016\/j.pharma.2008.11.004_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/01688639508405147","article-title":"Effects of aging and of Alzheimer's disease on verbal memory","volume":"17","author":"Incalzi","year":"1995","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.pharma.2008.11.004_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.46.2.329","article-title":"Testing cognition may contribute to the diagnosis of movement disorders","volume":"46","author":"Pillon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/WNL.52.2.231","article-title":"Screening for dementia with the memory impairment screen","volume":"52","author":"Buschke","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib13","first-page":"1696","article-title":"\u00ab\u00a0Les 5 mots\u00a0\u00bb, \u00e9preuve simple et sensible pour le diagnostic de la maladie d\u2019Alzheimer","volume":"31","author":"Dubois","year":"2002","journal-title":"Presse Med"},{"key":"10.1016\/j.pharma.2008.11.004_bib14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-9452(76)80035-4","article-title":"Modified card sorting test sensitive to frontal lobe defects","volume":"12","author":"Nelson","year":"1976","journal-title":"Cortex"},{"key":"10.1016\/j.pharma.2008.11.004_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indication of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.pharma.2008.11.004_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/h0054651","article-title":"Studies of interference in serial verbal reactions","volume":"18","author":"Stroop","year":"1935","journal-title":"J Exp Psychol"},{"key":"10.1016\/j.pharma.2008.11.004_bib17","first-page":"207","article-title":"\u00c9vocation lexicale formelle et s\u00e9mantique chez des sujets normaux. Performances et dynamiques de la production en fonction du sexe, de l\u2019\u00e2ge et du niveau d\u2019\u00e9tude","volume":"90","author":"Cardebat","year":"1990","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.pharma.2008.11.004_bib18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(05)70219-2","article-title":"Behavioural changes and psychological symptoms in dementia disorders","volume":"4","author":"McKeith","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib19","doi-asserted-by":"crossref","unstructured":"Finkel S, Burns A. Introduction. In: Ames D, O\u2019Brien J (eds.). Behavioral and psychological symptoms of dementia (BPSD): a clinical and research update. International Psychogeriatrics 2000;12:9\u201312.","DOI":"10.1017\/S1041610200007031"},{"key":"10.1016\/j.pharma.2008.11.004_bib20","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib21","first-page":"63","article-title":"L\u2019inventaire neuropsychiatrique\u00a0: validation de la version fran\u00e7aise d\u2019un instrument destin\u00e9 \u00e0 \u00e9valuer les troubles du comportement chez le sujet dement","volume":"5","author":"Robert","year":"1998","journal-title":"Annee Gerontol"},{"key":"10.1016\/j.pharma.2008.11.004_bib22","first-page":"9","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.eurpsy.2004.09.031","article-title":"Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium","volume":"20","author":"Robert","year":"2005","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/WNL.46.1.130","article-title":"The spectrum of behavioral changes in Alzheimer's disease","volume":"46","author":"Mega","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib25","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1532-5415.1992.tb01802.x","article-title":"Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers","volume":"40","author":"Barberger-Gateau","year":"1992","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pharma.2008.11.004_bib26","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2018s disease","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.pharma.2008.11.004_bib27","unstructured":"Anaes. Recommandations pratiques pour le diagnostic de maladie d\u2019Alzheimer. Anaes 2000."},{"key":"10.1016\/j.pharma.2008.11.004_bib28","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ageing\/22.6.457","article-title":"Four instrumental activities of daily linving score as a predictor of 1-year incident dementia","volume":"22","author":"Barberger-Gateau","year":"1993","journal-title":"Age Ageing"},{"key":"10.1016\/j.pharma.2008.11.004_bib29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The global deterioration scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib30","unstructured":"Manos Peter 10-Point clock test screens for cognitive impairment in clinic and hospital settings. Psychiatric Times 1998;15:10."},{"key":"10.1016\/j.pharma.2008.11.004_bib31","series-title":"Wechsler adult intelligence scale-revised manual","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.pharma.2008.11.004_bib32","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IV). ed. Washington, 1994."},{"key":"10.1016\/j.pharma.2008.11.004_bib33","unstructured":"Opeps. Rapport sur la maladie d\u2019Alzheimer et les maladies apparent\u00e9es par Mme C\u00e9cile Gallez. Enregistr\u00e9 \u00e0 la Pr\u00e9sidence de l\u2019Assembl\u00e9e Nationale le 6 juillet 2005 sous le num\u00e9ro 2454."},{"key":"10.1016\/j.pharma.2008.11.004_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1368-504X.2005.00480.x","article-title":"Inequalities in dementia care across Europe: key findings of the facing dementia survey","volume":"146","author":"Bond","year":"2005","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.pharma.2008.11.004_bib35","unstructured":"World Health Organization. ICD-10: International statistical classification of diseases and related health problems: based on recommendations of the tenth revision conference, 1989 and adopted by the forty-third World Health Assembly. 10th revision edition. 1992."},{"key":"10.1016\/j.pharma.2008.11.004_bib36","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1995.00540300086018","article-title":"Cognitive impairment in the non-demented elderly: results from the canadian study of health and aging","volume":"52","author":"Ebly","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.41.7.1006","article-title":"Mild cognitive impairment in the elderly: predictors of dementia","volume":"41","author":"Flicker","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(04)00710-0","article-title":"Amnestic MCI or prodromal Alzheimer's disease?","volume":"3","author":"Dubois","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/87565648709540361","article-title":"Genuine memory deficit in dementia","volume":"3","author":"Grober","year":"2006","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/j.pharma.2008.11.004_bib41","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1212\/WNL.48.4.989","article-title":"Diagnosis of early dementia by the double memory test: encoding specificity improves diagnostic sensitivity and specificity","volume":"48","author":"Buschke","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.44.5.867","article-title":"Memory function in very early Alzheimer's disease","volume":"44","author":"Petersen","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002093-199903000-00006","article-title":"Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease","volume":"13","author":"Tounsi","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.pharma.2008.11.004_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","article-title":"Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion","volume":"1","author":"Scheltens","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.neuroimage.2006.10.035","article-title":"Anatomically constrained region deformation for the automated segmentation of the hippocampus and the amygdale: method and validation on controls and patients with Alzheimer's disease","volume":"34","author":"Chupin","year":"2007","journal-title":"Neuroimage"},{"key":"10.1016\/j.pharma.2008.11.004_bib46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S1041610202008281","article-title":"Volumetric MRI measurements can differentiate Alzheimer's disease, mild cognitive impairment, and normal aging","volume":"14","author":"Bottino","year":"2002","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.pharma.2008.11.004_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0197-4580(98)00006-2","article-title":"MRI of the hippocampus in Alzheimer's disease: sensitivity, specificity and analysis of the incorrectly classified subjects","volume":"19","author":"Laakso","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2008.11.004_bib48","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s004150050387","article-title":"Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment","volume":"246","author":"Visser","year":"1999","journal-title":"J Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib49","first-page":"491","article-title":"Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment","volume":"72","author":"Visser","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000133114.92694.93","article-title":"Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment","volume":"63","author":"Korf","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib51","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/WNL.48.5.1297","article-title":"Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia","volume":"48","author":"Kaye","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib52","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib53","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/gps.1392","article-title":"MRI measures and progression of cognitive decline in nondemented elderly attending a memory clinic","volume":"20","author":"Van Der Flier","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410380413","article-title":"Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease","volume":"38","author":"Motter","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib55","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2008.11.004_bib56","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0304-3940(02)00047-2","article-title":"Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients","volume":"320","author":"Hu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharma.2008.11.004_bib57","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib58","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nic.2005.09.007","article-title":"Positron emission tomography diagnosis of Alzheimer's disease","volume":"15","author":"Coleman","year":"2005","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.pharma.2008.11.004_bib59","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.56.7.950","article-title":"SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study","volume":"56","author":"Jagust","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1148\/radiol.2311021620","article-title":"Alzheimer disease: operating characteristics of PET \u2013 a meta-analysis","volume":"231","author":"Patwardhan","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.pharma.2008.11.004_bib61","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7342","article-title":"Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies","volume":"162","author":"Higuchi","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib62","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","article-title":"Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation","volume":"50","author":"Minoshima","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib63","first-page":"936","article-title":"11C-DTBZ and 18F-FDG PET measures in differentiating dementias","volume":"46","author":"Koeppe","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharma.2008.11.004_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000116474","article-title":"Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia","volume":"29","author":"Duara","year":"1989","journal-title":"Eur Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0013-4694(94)90034-5","article-title":"Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia","volume":"91","author":"Szelies","year":"1994","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.pharma.2008.11.004_bib66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib67","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.pharma.2008.11.004_bib68","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib69","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1001\/archneur.62.11.1728","article-title":"Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease","volume":"62","author":"Anchisi","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharma.2008.11.004_bib70","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/01.wnl.0000240117.55680.0a","article-title":"Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease","volume":"67","author":"Kemppainen","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2008.11.004_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00019442-200411000-00002","article-title":"Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia","volume":"12","author":"Dougall","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.pharma.2008.11.004_bib72","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.neurobiolaging.2006.05.017","article-title":"Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT","volume":"28","author":"Huang","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2008.11.004_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2004.12.010","article-title":"Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD","volume":"27","author":"Borroni","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2008.11.004_bib74","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1051\/medsci\/20021867717","article-title":"M\u00e9tabolisme du pr\u00e9curseur du peptide amylo\u00efde et pr\u00e9s\u00e9nilines","author":"Checler","year":"2002","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.pharma.2008.11.004_bib75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1051\/medsci\/20021867727","article-title":"La maladie d\u2019Alzheimer\u00a0: une tauopathie parmi d\u2019autres\u00a0?","author":"Bu\u00e9","year":"2002","journal-title":"Med Sci (Paris)"},{"key":"10.1016\/j.pharma.2008.11.004_bib76","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/S0197-4580(97)00067-5","article-title":"Diagnosis and staging of Alzheimer disease","volume":"18","author":"Duyckaerts","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharma.2008.11.004_bib77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharma.2008.11.004_bib78","first-page":"253","article-title":"Four neuropsychological profiles in dementia","volume":"8","author":"Weintraub","year":"1993"},{"key":"10.1016\/j.pharma.2008.11.004_bib79","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002093-199903000-00006","article-title":"Sensitivity to semantic cuing: an index of episodic memory dysfunction in early Alzheimer disease","volume":"13","author":"Tounsi","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450908001648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450908001648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:27:04Z","timestamp":1757719624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450908001648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0003450908001648"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2008.11.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s de la maladie d\u2019Alzheimer","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2008.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}